Figure 1.

The Beautification archetype. Pretreatment (A, C) and post‐treatment (B, D). The treatment approach designed for the patient involved primary management of her lower temple and lateral suborbicularis oculi fat (SOOF) using VYC^a‐17.5L^b and deep malar fat pad using VYC‐20L to increase the maxillary projection and support the orbital retaining ligament. Secondary stage involved direct management to inferior orbital rim (lateral and central) using VYC‐15L onto periosteum. Patient photographs provided by Jonquille Chantrey. ^aVYC, Vycross; ^bL, Lidocaine